CLOV vs TGTX · rev $1.37B vs P/E 18, rev $616.3M
Clover Health Investments Corp (CLOV) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TGTX revenue for 2025-12-31 was $616.3M. Net income was $447.2M. Revenue was up 87.3% from 2024-12-31 to 2025-12-31. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
CLOV currently screens at market cap $1.55B. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the CLOV and TGTX stock pages for the full models.
Not investment advice.